News Detail
SALT LAKE CITY, 27 FEB 2018: Activity of anti-CD22 chimeric antigen receptor T-cell therapy occurred among children and young adults with extramedullary acute lymphoblastic leukemia, despite delayed time to optimal response, according to study results presented at BMT Tandem Meet......
View Details
Source : Healio
Related News
- Scientists have discovered potential treatment for nicotine addiction (25-09-2023)
- Immune Cells Vital to Success of Vaccines Against Coronavirus: Study (24-09-2023)
- New target to beat cancer drug resistance (21-09-2023)
- New implantable device carries insulin-producing islet cells to control diabetes (20-09-2023)
- IIT Madras Researchers Developing A Portable, Turnkey Device To Detect Heavy Metals In Soil & Water (20-09-2023)
- Understanding Medicinal Drug Delivery Using Dry Powder Inhalers (DPIs) (20-09-2023)
- Molnupiravir: Concerns raised about possibility of creating new, treatment-resistant versions of the virus (19-09-2023)
- Various PFAS associated with breast, ovary, skin and uterus cancers in women (19-09-2023)
- IIT Jodhpur researchers develop antimicrobial peptide from snake venom (18-09-2023)
- Metformin, a common diabetes drug, can prevent muscle atrophy and fibrosis (17-09-2023)